Core Insights - Cofactor Genomics has received strategic investments from Labcorp and Ascension Ventures to enhance its operations and expand its market presence [1] Company Summary - Cofactor Genomics is a commercial-stage diagnostics company focused on transforming precision oncology through RNA-based predictive tests [1] - The new financing aims to accelerate Cofactor's nationwide expansion and increase patient access to its immunotherapy-response diagnostics [1] Industry Context - Ascension Ventures is the strategic investment arm of 13 leading U.S. health systems across 22 states, representing over $100 billion in assets [1]